ULBP1 Antibodies

Santa Cruz Biotechnology features a diverse variety of ULBP1 monoclonal antibodies for research in understanding ULBP1's role in immune response and cellular signaling. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ULBP1, or UL16 binding protein 1, is a member of the NKG2D ligand family and plays a crucial role in the activation of natural killer (NK) cells and T cells. By binding to the NKG2D receptor on immune cells, ULBP1 contributes to the recognition and elimination of stressed or transformed cells, making it a significant factor in tumor immunology and viral infections. Understanding ULBP1 function is essential for developing therapeutic strategies aimed at enhancing immune responses against cancer and infectious diseases. Research with ULBP1 monoclonal antibodies enables exploration of cellular pathways and molecular interactions. Investigating ULBP1 expression patterns helps reveal its role in various physiological and pathological conditions. Advanced research techniques using ULBP1 monoclonal antibodies support the development of novel therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies for ULBP1 research contribute to advancing our understanding of immune system regulation and potential therapeutic applications.